Future healthcare journal · 2025
Extended reality in supporting cancer patients and survivors: A systematic review on the benefits and challenges across the cancer care continuum.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Elkefi Safa, Tounsi Achraf, Boudiche Siwar, Matthews Alicia K, Hernandez Rose, Lourimi Noureddine
Аннотация
PURPOSE: Our study explores the role of extended reality (XR) in supporting cancer patients.
METHODS: A systematic search was conducted across six electronic databases. We adhered to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) reviews.
RESULTS: We included 62 studies. XR technologies were mainly applied during the treatment phase (64.5% of studies), with additional applications in palliative care and during survivorship (33.9%). One study addressed the diagnosis phase, and none supported prevention or early detection. XR showed effective results supporting patients in seven areas: anxiety and stress reduction (n = 40), pain management (n = 19) and symptom tracking (n = 14). Challenges identified related to physical discomfort, technical issues, and user compliance.
CONCLUSIONS: XR interventions demonstrate significant potential in improving patient outcomes, particularly in anxiety reduction and symptom management. However, their application remains unevenly distributed across the cancer care continuum.
METHODS: A systematic search was conducted across six electronic databases. We adhered to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) reviews.
RESULTS: We included 62 studies. XR technologies were mainly applied during the treatment phase (64.5% of studies), with additional applications in palliative care and during survivorship (33.9%). One study addressed the diagnosis phase, and none supported prevention or early detection. XR showed effective results supporting patients in seven areas: anxiety and stress reduction (n = 40), pain management (n = 19) and symptom tracking (n = 14). Challenges identified related to physical discomfort, technical issues, and user compliance.
CONCLUSIONS: XR interventions demonstrate significant potential in improving patient outcomes, particularly in anxiety reduction and symptom management. However, their application remains unevenly distributed across the cancer care continuum.